News & events

Latest news and upcoming events

Every day we make new research discoveries, deliver excellence in education and forge partnerships that have a global impact.

Search news

Browse by category

Browse:

Select all - Clear all
filepath://C:\fakepath\Peanut-Allergy_group_19-for-web.jpg

New peanut allergy treatment now in clinical trials

A new peanut allergy treatment developed by Monash researchers is now beginning clinical trials in Melbourne and Adelaide.

Medicine & health
filepath://C:\fakepath\anaesthesia-555x350.jpg

Monash Professor Paul Myles wins Clinical Trial of the Year award – presented by Federal Health Minister

Monash University Professor Paul Myles has won Clinical Trial of the Year, awarded by the Australian Clinical Trials Alliance (ACTA).  The award was presented by Federal Health Minister, the Hon Greg Hunt MP, on Friday 19 May 2017.

Medicine & health
filepath://C:\fakepath\lungs-555x350.jpg

Poor sleep in kids with Cystic Fibrosis may impact overall health

A Monash University study into the sleep patterns of children with Cystic Fibrosis (CF) has found, even when the disease is clinically stable, they experience less sleep than healthy children, impacting their health and quality of life.

Medicine & health
Superbug

Key to 'superbug' antibiotic resistance discovered

An international study led by Monash University has discovered the molecular mechanism by which the potentially deadly superbug ‘Golden Staph’ evades antibiotic treatment, providing the first important clues on how to counter superbug antibi

Medicine & health
Prof Helena Teede

Monash Partners receives funding boost in Federal budget – with health benefits to Victorians

The health of Victorians and Australians is set to improve with the announcement of significant Federal Government investment to support Advanced Health Research and Translation Centres including Monash Partners (which encompasses Monash University

Medicine & health

Monash University and Corvus Pharmaceuticals enter into exclusive license agreement for Novel Immuno-Oncology Program

Monash University and Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company, have announced today they have entered into an exclusive agreement. Under the agreement, Corvus has licensed global rights to an

Medicine & health
Christian and Reza

Study points to new approach to battling infections

An international study led by researchers at Monash University’

Medicine & health